Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods

被引:30
|
作者
Bertrand, Dominique [1 ,2 ]
Pallet, Nicolas [2 ,3 ]
Sartorius, Albane [1 ,2 ]
Zahar, Jean Ralph [2 ,4 ]
Soussan, Rebecca Sberro [1 ,2 ]
Lortholary, Olivier [2 ,5 ]
Legendre, Christophe [1 ,2 ]
Mamzer, Marie-France [1 ,2 ]
机构
[1] Hop Necker Enfants Malad, Serv Transplantat Renale & Soins Intensifs, Paris, France
[2] Univ Paris 05, Paris, France
[3] Hop Europeen Georges Pompidou, Serv Nephrol, F-75015 Paris, France
[4] Hop Necker Enfants Malad, Microbiol Serv, Paris, France
[5] Hop Necker Enfants Malad, Serv Malad Infect, Paris, France
关键词
allograft; bacterial contamination; infection; Kidney; preservation fluid; INFECTIONS; FLUID; DONOR;
D O I
10.1111/tri.12130
中图分类号
R61 [外科手术学];
学科分类号
摘要
The clinical and bacteriological consequences of routinely performing highly sensitive bacterial screening of kidney transplant preservation solution (PS) are not known. To evaluate the clinical and microbiological impacts of this strategy, we retrospectively analyzed 200 consecutive kidney allograft recipients from March 2009 to February 2011 for whom PS samples were routinely screened. PS were inoculated into aerobic and anaerobic blood culture bottles, as well as blood agar plates. A rectal swab for extended-spectrum -lactamase-producing Enterobacteriaceae (EBSL-PE) faecal carriage was also routinely obtained from each patient at admission and every 7days until hospital discharge. In addition, a standard culture of drain fluid was collected on the day after kidney transplantation. Complete samples and cultures of PS were performed in 165 cases (82.5%), and 62 (37.6%) had positive blood culture results. The most frequent microbial agent isolated was coagulase-negative staphylococci (51.8%). Of these 62 positive samples, only seven (11.3%) were confirmed to contain the same organism by the standard culture method. Drain fluid and PS culture positivity with the same microorganism occurred in only two patients. Of the 62 patients with positive PS cultures, 26 (41.9%) received pre-emptive antibiotic therapy initiated within 48h post-transplant. During the hospitalization period, patients with a positive PS culture, regardless of whether they received pre-emptive antibiotic therapy, did not exhibit any invasive infections (urinary, blood, peritoneal or wound) related to the microorganisms isolated in the PS. Patients with positive PS cultures who were treated with antibiotic therapy acquired significantly more colonizing ESBL-PE than patients who did not receive antibiotics (53.8% vs. 16.6%; P=0.01); these patients also developed more clinical infections related to the ESBL-PE (23.1% vs. 5.2%; P<0.01). The use of antibiotics for patients with positive PS cultures was an independent risk factor for ESBL-PE acquisition in both univariate and multivariate analyses. In conclusion, the use of more sensitive culture methods increases the rate of bacterial contamination of PS and is associated with an increased prescription of antibiotics and increased ESBL-PE carriage and related infections. Therefore, the systematic use of PS blood bottle cultures in kidney transplantation may have no benefit and might increase the rate of ESBL-PE emergence.
引用
收藏
页码:795 / 799
页数:5
相关论文
共 38 条
  • [31] Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin
    Kuo-Ho Yeh
    Tzu-Hsien Tsai
    Han-Tan Chai
    Steve Leu
    Sheng-Ying Chung
    Sarah Chua
    Yung-Lung Chen
    Hung-Sheng Lin
    Chun-Man Yuen
    Hon-Kan Yip
    Journal of Translational Medicine, 10
  • [32] Methodology to Evaluate Clinical Impact of 0/3 Hour High-Sensitivity Cardiac Troponin T Protocol on Managing Acute Coronary Syndrome in Daily Emergency Department Practice
    Bellini, Claudia
    Cinci, Francesca
    Bova, Giovanni
    Mascarucci, Monica
    Leoncini, Roberto
    Scapellato, Carlo
    Guerranti, Roberto
    LABORATORY MEDICINE, 2021, 52 (05) : 452 - 459
  • [33] Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin
    Yeh, Kuo-Ho
    Tsai, Tzu-Hsien
    Chai, Han-Tan
    Leu, Steve
    Chung, Sheng-Ying
    Chua, Sarah
    Chen, Yung-Lung
    Lin, Hung-Sheng
    Yuen, Chun-Man
    Yip, Hon-Kan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [34] Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2 (vol 47, pg 418 2001)
    Roberts, WL
    Moulton, L
    Law, TC
    Farrow, G
    Cooper-Anderson, M
    Savory, J
    Rifai, N
    CLINICAL CHEMISTRY, 2001, 47 (05) : 980 - 980
  • [35] Impact of the clinical introduction of high-sensitivity cardiac troponin T assay on rates of coronary angiographies and exercise stress tests in acute chest pain - Insights from an international trial
    Twerenbold, R.
    Reichlin, T.
    Reiter, M.
    Haaf, P.
    Gimenez, M. Rubini
    Wildi, K.
    Osswald, S.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 983 - 984
  • [36] Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention
    Shitara, Jun
    Ogita, Manabu
    Wada, Hideki
    Tsuboi, Shuta
    Endo, Hirohisa
    Doi, Shinichiro
    Konishi, Hirokazu
    Naito, Ryo
    Dohi, Tomotaka
    Kasai, Takatoshi
    Okazaki, Shinya
    Isoda, Kikuo
    Suwa, Satoru
    Miyauchi, Katsumi
    Daida, Hiroyuki
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 45 - 50
  • [37] Traditional clinical criteria outperform high-sensitivity C-reactive protein for the screening of hepatic nuclear factor 1 alpha maturity-onset diabetes of the young among young Asians with diabetes
    Chandran, Suresh Rama
    Bhalshankar, Jaydutt
    Vasanwala, Rashida Farhad
    Zhao, Yi
    Owen, Katharine R.
    Gardner, Daphne Su-Lyn
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (09) : 271 - 282
  • [38] Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation
    Hsieh, I-Chang
    Chen, Chun-Chi
    Hsieh, Ming-Jer
    Yang, Chia-Hung
    Chen, Dong-Yi
    Chang, Shang-Hung
    Wang, Chao-Yung
    Lee, Cheng-Hung
    Tsai, Ming-Lung
    PLOS ONE, 2015, 10 (09):